The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiteness, brightness, opacity, and protection in various of applications. The Thermal & Specialized Solutions segment offers of refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment provides polymers and advanced materials. Its Chemical Solutions segment offers industrial chemicals used in gold production, industrial, and consumer applications. The company sells its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.
IPO Year: 2015
Exchange: NYSE
Website: chemours.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/9/2024 | $28.00 → $30.00 | Neutral → Buy | UBS |
| 6/7/2024 | $25.00 | Neutral | Mizuho |
| 4/9/2024 | $19.00 → $34.00 | Underperform → Outperform | BMO Capital Markets |
| 3/5/2024 | $37.00 → $21.00 | Buy → Neutral | UBS |
| 2/29/2024 | $45.00 → $19.00 | Outperform → Underperform | BMO Capital Markets |
| 12/1/2023 | $28.00 → $40.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 6/22/2023 | $41.00 → $37.00 | Buy → Neutral | BofA Securities |
| 1/24/2023 | $31.00 → $43.00 | Neutral → Buy | UBS |
| 1/11/2023 | $37.00 → $40.00 | Neutral → Buy | BofA Securities |
| 1/10/2023 | $35.00 → $33.00 | Outperform → Sector Perform | RBC Capital Mkts |
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
3 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
4 - Chemours Co (0001627223) (Issuer)
The Chemours Company (Chemours) (NYSE:CC) today announced the pricing of its previously announced private offering of $600,000,000 aggregate principal amount of new 8.000% senior notes due 2033 (the "Notes"). The Notes will bear interest at 8.000% per annum and mature on January 15, 2033. Interest on the Notes will be payable semi-annually on January 15 and July 15 of each year, beginning on July 15, 2025. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. The offering is expected to close on November 27, 2024, subject to customary closing conditions. Chemours intends to use the net proceeds from the offering to redeem all of
The Chemours Company (Chemours) (NYSE:CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2033 (the "Notes"), subject to market and other conditions. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by certain of its subsidiaries. Chemours intends to use the net proceeds from the offering to redeem all of its outstanding euro-denominated 4.000% senior notes due 2026 and the remainder of the net proceeds for general corporate purposes. The Notes and related guarantees are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securitie
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solu
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024. The Company expects to hold its conference call to discuss its third quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Monday, November 4, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC)
The fully integrable aftermarket approach will make it easy and cost effective for older vehicles to transition to climate-friendly Opteon™ YF (R-1234yf) The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the development of a low global warming potential (GWP) refrigerant retrofit approach for the automotive aftermarket to support the global phasedown of higher GWP hydrofluorocarbon (HFC) refrigerants. The technical approach developed will provide vehicle owners—and their service technicians—with a simple retrofit procedure to safely and cost effectively replace the legacy R-134a refrigerant in their existing vehicle w
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The facility will enable more sustainable, cost-effective, and high-performing EV batteries The Chemours Company (Chemours) (NYSE:CC), a global leader in delivering innovative performance chemistry, today announced the opening of the Chemours Battery Innovation Center (CBIC), a first-in-its-class laboratory facility located at the Chemours Discovery Hub in Newark, Delaware. A multi-million-dollar investment, the CBIC supports the testing and scaling of next generation battery technologies, to enable more sustainable, cost-effective, energy-efficient, and high-performing batteries for hybrid and electric vehicles (EVs). This press release features multimedia. View the full release here: h
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company expects to hold its conference call to discuss its second quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Friday, August 2, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (N
The Chemours Company ("Chemours" or "the Company") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced that the Mexican government has lifted its prior water intake restrictions, enabling the Company to resume normal operations at its titanium dioxide (TiO2) manufacturing facility in Altamira, Mexico. The Company previously announced a temporary pause in production on May 31, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its
8-K - Chemours Co (0001627223) (Filer)
10-Q - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
10-Q - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
8-K - Chemours Co (0001627223) (Filer)
UBS analyst Joshua Spector upgrades Chemours (NYSE:CC) from Neutral to Buy and raises the price target from $28 to $30.
Chemours's (NYSE:CC) short percent of float has fallen 8.66% since its last report. The company recently reported that it has 5.37 million shares sold short, which is 5.38% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.65 days to cover their short positions on average. Why Short Interest Matters Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises. Short interest is imp
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Chemours (NYSE:CC) in the last three months. The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 1 3 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 0 0 2 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $29.25, with a high estimate of $34.00 and a low estimate of $25.00. Observing a 21.88% increase, the current averag
Mizuho analyst John Roberts initiates coverage on Chemours (NYSE:CC) with a Neutral rating and announces Price Target of $25.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout. Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Below are the ratings of the most accurate analysts for three high-yielding stocks in the materials sector. Sonoco Products Company (NYSE:SON) Dividend Yield: 3.47% Citigroup analyst Anthony Pettinari maintained a Buy rating and cut the
Chemours will discontinue U.S. sales of these select Freon products as of May 2, 2024, in support of regulatory phasedown requirements. The strategy aligns with regulatory phasedowns of hydrofluorocarbons (HFCs), outlined under the American Innovation and Manufacturing (AIM) Act and Canada's Ozone-depleting Substances and Halocarbon Alternatives Regulations (ODSHAR).
Consolidated Adjusted EBITDA also to be up approximately 15% compared with first quarter 2024 results.
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the fourth quarter of 2024. The dividend will be paid on December 16, 2024 to stockholders of record as of the close of business on November 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solu
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its third quarter 2024 financial results before market on Monday, November 4, 2024. The Company expects to hold its conference call to discuss its third quarter 2024 financial results at 8:00 a.m. Eastern Standard Time on Monday, November 4, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYSE:CC)
The Chemours Company ("Chemours") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the third quarter of 2024. The dividend will be paid on September 13, 2024 to stockholders of record as of the close of business on August 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its second quarter 2024 financial results after market close on Thursday, August 1, 2024. The Company expects to hold its conference call to discuss its second quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Friday, August 2, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (N
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced the Board of Directors of Chemours declared a quarterly cash dividend of $0.25 per share on the Company's common stock for the second quarter of 2024. The dividend will be paid on June 14, 2024 to stockholders of record as of the close of business on May 15, 2024. About The Chemours Company The Chemours Company (NYSE:CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solut
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company expects to issue its first quarter 2024 financial results after market close on Tuesday, April 30, 2024. The Company expects to hold its conference call to discuss its first quarter 2024 financial results at 8:00 a.m. Eastern Daylight Time on Wednesday, May 1, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Replay: A webcast replay will be available at investors.chemours.com. About The Chemours Company The Chemours Company (NYS
The company was recognized for its achievements in energy efficiency and waste reduction at the DOE Better Buildings, Better Plants Summit The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, was honored yesterday with two awards from the U.S. Department of Energy's (DOE) Better Buildings, Better Plants initiative, which recognizes partners for outstanding accomplishments in energy efficiency, decarbonization, water efficiency, or waste reduction projects or practices. This is the second year that Chemours has been recognized with both Better Proj
The Chemours Company ("Chemours" or "the Company") (NYSE:CC) today announced that the Company currently expects to issue its fourth quarter and full year 2023 financial results and file its Annual Report on Form 10-K for the year ended December 31, 2023 after market close on Wednesday, March 27, 2024. The Company expects to hold its conference call to discuss its fourth quarter and full year 2023 financial results at 8:00 a.m. Eastern Daylight Time on Thursday, March 28, 2024. The call is open to the public and can be accessed via the below webcast information. Conference Call: Please visit investors.chemours.com for a link to the live webcast and to view the accompanying slides. Repl
On March 18, 2024, The Chemours Company ("Chemours" or "the Company") (NYSE:CC) received notice from the New York Stock Exchange (the "NYSE") that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Annual Report on Form 10-K for the year ended December 31, 2023, with the Securities and Exchange Commission (the "SEC"). The NYSE informed the Company that, under the NYSE's rules, the Company will have six months from March 15, 2024 to file the Form 10-K with the SEC. The Company can regain compliance with the NYSE listing standards by filing the Form 10-K with the SEC before such date. As previously disclosed in the Company'
RADNOR, Pa., March 11, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of The Chemours Company (NYSE:CC) ("Chemours"). On February 13, 2024, during after-market hours, Chemours issued a press release announcing that the company had "postponed the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2023." Specifically, Chemours stated that it "is delaying the release of financial results and the conference call because it needs additional time to complete its year-end reporting process. The
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
SC 13G/A - Chemours Co (0001627223) (Subject)
UBS upgraded Chemours from Neutral to Buy and set a new price target of $30.00 from $28.00 previously
Mizuho initiated coverage of Chemours with a rating of Neutral and set a new price target of $25.00
BMO Capital Markets upgraded Chemours from Underperform to Outperform and set a new price target of $34.00 from $19.00 previously
UBS downgraded Chemours from Buy to Neutral and set a new price target of $21.00 from $37.00 previously
BMO Capital Markets downgraded Chemours from Outperform to Underperform and set a new price target of $19.00 from $45.00 previously
RBC Capital Mkts upgraded Chemours from Sector Perform to Outperform and set a new price target of $40.00 from $28.00 previously
BofA Securities downgraded Chemours from Buy to Neutral and set a new price target of $37.00 from $41.00 previously
UBS upgraded Chemours from Neutral to Buy and set a new price target of $43.00 from $31.00 previously
BofA Securities upgraded Chemours from Neutral to Buy and set a new price target of $40.00 from $37.00 previously
RBC Capital Mkts downgraded Chemours from Outperform to Sector Perform and set a new price target of $33.00 from $35.00 previously
Mr. Satterthwaite Brings Over 30 Years of Global Power Generation Experience to Amprius Technologies Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE:AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, has appointed Livingston "Tony" Satterthwaite as an independent director on its Board of Directors (the "Board"), effective August 13, 2024. Mr. Satterthwaite will also be joining the Board's Compensation Committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240814317462/en/Amprius Appoints Transportation Industry Veteran Tony Satterthwaite to Board of Directors (Photo: Busi
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Livingston "Tony" Satterthwaite to its Board of Directors, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240613653963/en/Tony Satterthwaite named to Chemours' Board of Directors (Photo: Business Wire) "I'm pleased to welcome Tony as the newest member of Chemours' Board of Directors," said Dawn Farrell, Chair of the Board of Chemours. "Tony brings extensive leadership and board expe
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Shane Hostetter as Chief Financial Officer (CFO) effective July 1, 2024. As CFO, Shane will lead Finance, Investor Relations, Corporate Development, Strategy, and Enterprise Risk Management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240605314740/en/Shane Hostetter, Chief Financial Officer (Photo: Business Wire) "Shane is a welcome addition to the Chemours team. With over 20 years' experience in a
LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' opt
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 09, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 01, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' opt
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, March 25, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises The Chemours Company ("Chemours" or the "Company") (NYSE:CC) investors that a lawsuit was filed on behalf of investors that purchased Chemours securities between February 10, 2023 and February 28, 2024, inclusive (the "Class Period"). Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: [email protected], to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' o
The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Denise Dignam, current Interim Chief Executive Officer, to the positions of President and Chief Executive Officer and a member of the Board of Directors, effective immediately. Ms. Dignam joined Chemours in 2015. She brings over 35 years of experience in the chemical industry where she has held senior roles in business and operations, sales and marketing, commercialization, and supply chain. She had served as Interim Chief Executive Officer since February 2024,
SINGAPORE, Aug. 23, 2023 /PRNewswire/ -- Kulicke and Soffa Industries, Inc. (NASDAQ:KLIC) ("Kulicke & Soffa," "K&S" or the "Company") today announced the appointment of Denise M. Dignam to its Board of Directors. Ms. Dignam serves as President of The Chemours Company (NYSE:CC) (Chemours) Titanium Technologies (TT) business, one of the largest manufacturers of Titanium Dioxide (TiO2) in the world. She has over 35 years of chemical industry experience across multiple areas including commercialization, sales and marketing, strategy, supply chain and operations leadership. Ms. Dig
New Leader Poised to Continue Delivering Strong Performance The Chemours Company ("Chemours") (NYSE:CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, today announced the appointment of Joseph Martinko as President, Thermal & Specialized Solutions (TSS), effective immediately. Martinko was appointed interim leader on June 1 and stood out as the top candidate following an internal and external search. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230726287313/en/Joseph Martinko President, Thermal & Specialized Solutions Ch